Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays
Cytometry Part B: Clinical Cytometry · 2023-09 · 104 (5) · 374-391
DOI: 10.1002/cyto.b.22123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 03.05.2023. Verfasst von Katherine A Devitt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Hemoglobinuria, Paroxysmal, Leukemia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In the clinical laboratory, flow cytometry assays are critical to providing diagnostic and prognostic information to the treating clinicians. A validation or verification provides confidence that the assay will yield reliable results that can be trusted to make critical medical decisions. The following performance specifications should be included in a validation for laboratory developed tests as needed: accuracy (or trueness), precision (reproducibility and repeatability), detection capability, selectivity, reference range, and sample and reagent stability. We define these terms and present our approach to validation of several common flow cytometry assays, including examples of a leukemia/lymphoma assay and a paroxysmal nocturnal hemoglobinuria (PNH) assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.
- Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
- Oldaker Consulting, San Clemente, California, USA.
- Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
- Dahl-Chase Diagnostic Services, Bangor, Maine, USA.
Zitieren
APA
Devitt, K. A., Oldaker, T., Shah, K., & Illingworth, A. (2023). Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays. Cytometry Part B: Clinical Cytometry, 104(5), 374-391. https://doi.org/10.1002/cyto.b.22123
Vancouver
Devitt KA, Oldaker T, Shah K, Illingworth A. Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays. Cytometry Part B: Clinical Cytometry. 2023;104(5):374-391. doi:10.1002/cyto.b.22123
BibTeX
@article{Devitt2023,
author = {Devitt, Katherine A and Oldaker, Teri and Shah, Kalpesh and Illingworth, Andrea},
title = {Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2023},
volume = {104},
number = {5},
pages = {374--391},
doi = {10.1002/cyto.b.22123}
}
EUVIMED